Ratings JVM Co., Ltd.

Equities

A054950

KR7054950001

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-07-15 pm EDT			5-day change	1st Jan Change
27,400 ^KRW	+0.18%		+2.62%	+3.40%

May. 16	JVM Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 12	JVM Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
The company's Refinitiv ESG score, based on a relative ranking of the company within its sector, comes out particularly poor.

Strengths

The company returns high margins, thereby supporting business profitability.
Thanks to a sound financial situation, the firm has significant leeway for investment.
With a P/E ratio at 10.8 for the current year and 9.3 for next year, earnings multiples are highly attractive compared with competitors.
Given the positive cash flows generated by its business, the company's valuation level is an asset.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Considering the small differences between the analysts' various estimates, the group's business visibility is good.
The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Over the past twelve months, analysts' opinions have been revised negatively.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Advanced Medical Equipment & Technology

	1st Jan change	Capi.	ESG Refinitiv
JVM CO., LTD.	+3.40%	228M	D
THERMO FISHER SCIENTIFIC	+4.64%	212B	B
DANAHER CORPORATION	+8.99%	187B	B-
INTUITIVE SURGICAL, INC.	+29.83%	155B	B-
BOSTON SCIENTIFIC CORPORATION	+35.17%	115B	A-
SIEMENS HEALTHINEERS AG	+1.75%	65.5B	A-
EDWARDS LIFESCIENCES CORPORATION	+15.06%	52.87B	B+
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-6.47%	45.25B	B+
AGILENT TECHNOLOGIES, INC.	-2.14%	39.7B	A
GE HEALTHCARE TECHNOLOGIES INC.	+6.88%	37.72B	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders